Literature DB >> 33692530

Attributes and predictors of long COVID.

Sebastien Ourselin1,2, Tim Spector3, Claire J Steves4, Carole H Sudre5,6,1, Benjamin Murray1, Thomas Varsavsky1, Mark S Graham1, Rose S Penfold3, Ruth C Bowyer7, Joan Capdevila Pujol7, Kerstin Klaser1, Michela Antonelli1, Liane S Canas1, Erika Molteni1, Marc Modat1, M Jorge Cardoso1, Anna May7, Sajaysurya Ganesh7, Richard Davies7, Long H Nguyen8, David A Drew8, Christina M Astley9, Amit D Joshi8, Jordi Merino10,11,12, Neli Tsereteli13, Tove Fall14, Maria F Gomez13, Emma L Duncan3, Cristina Menni3, Frances M K Williams3, Paul W Franks3,13, Andrew T Chan8, Jonathan Wolf7.   

Abstract

Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app1. A total of 558 (13.3%) participants reported symptoms lasting ≥28 days, 189 (4.5%) for ≥8 weeks and 95 (2.3%) for ≥12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio = 3.53 (2.76-4.50)). A simple model to distinguish between short COVID and long COVID at 7 days (total sample size, n = 2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.

Entities:  

Year:  2021        PMID: 33692530     DOI: 10.1038/s41591-021-01292-y

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  404 in total

1.  Smartphone science: apps test and track infectious diseases.

Authors:  Sandeep Ravindran
Journal:  Nature       Date:  2021-05       Impact factor: 49.962

2.  The four most urgent questions about long COVID.

Authors:  Michael Marshall
Journal:  Nature       Date:  2021-06       Impact factor: 49.962

3.  Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.

Authors:  Ming Zheng
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

Review 4.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

Review 5.  Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.

Authors:  Timothy L Wong; Danielle J Weitzer
Journal:  Medicina (Kaunas)       Date:  2021-04-26       Impact factor: 2.430

6.  Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.

Authors:  Dominic Paquin-Proulx; Bronwyn M Gunn; Aljawharah Alrubayyi; Danielle V Clark; Matthew Creegan; Dohoon Kim; Hannah Kibuuka; Monica Millard; Salim Wakabi; Leigh Anne Eller; Nelson L Michael; Randal J Schoepp; Matthew J Hepburn; Lisa E Hensley; Merlin L Robb; Galit Alter; Michael A Eller
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

7.  ["Long-haul COVID": An opportunity to address the complexity of post-infectious functional syndromes].

Authors:  P Cathébras; J Goutte; B Gramont; M Killian
Journal:  Rev Med Interne       Date:  2021-06-09       Impact factor: 0.728

8.  Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.

Authors:  Kathrine Agergård Kaspersen; Thomas Greve; Kent Jacob Nielsen; Sanne Jespersen; Susan Mikkelsen; Jesper Medom Vestergaard; Jacob Dvinge Redder; Martin Tolstrup; Marianne Kragh Thomsen; Holger Jon Møller; Lars Østergaard; Henrik Albert Kolstad; Christian Erikstrup
Journal:  Int J Infect Dis       Date:  2021-06-11       Impact factor: 3.623

9.  Weakly unsupervised conditional generative adversarial network for image-based prognostic prediction for COVID-19 patients based on chest CT.

Authors:  Tomoki Uemura; Janne J Näppi; Chinatsu Watari; Toru Hironaka; Tohru Kamiya; Hiroyuki Yoshida
Journal:  Med Image Anal       Date:  2021-07-11       Impact factor: 8.545

Review 10.  Managing diabetes in diabetic patients with COVID: where do we start from?

Authors:  Angelo Avogaro; Benedetta Bonora; Gian Paolo Fadini
Journal:  Acta Diabetol       Date:  2021-06-25       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.